Clinical trial
L-Carnosine for Bipolar I Disorder
NCT00177463 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00177463 |
|---|---|
| Title | L-Carnosine for Bipolar I Disorder |
| Official title | A Pilot Add-on Randomized, Placebo Controlled Intervention Trial of Cognitive Enhancement in Persons With Bipolar Disorder Using an Antioxidant and Advanced Glycation End (AGE) Product Inhibitor: L-Carnosine |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Study type | Interventional |
| Conditions | Bipolar I Disorder |
| Intervention type | Drug |
| Interventions | L-carnosine |
| Enrollment | 47 |
| Start date | Sep 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: